Stocks and Investing
Stocks and Investing
Tue, September 3, 2024
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
[ Tue, Sep 03rd 2024
] - WOPRAI
Ed Arce Reiterated (UNCY) at Strong Buy and Held Target at $2.5 on, Sep 3rd, 2024
Ed Arce of HC Wainwright & Co., Reiterated "Unicycive Therapeutics, Inc." (UNCY) at Strong Buy and Held Target at $2.5 on, Sep 3rd, 2024.
Ed has made no other calls on UNCY in the last 4 months.
There is 1 other peer that has a rating on UNCY. Out of the 1 peers that are also analyzing UNCY, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Bruce Jackson of "Benchmark" Reiterated at Buy and Held Target at $3 on, Monday, June 3rd, 2024
Contributing Sources